Wuhan Keqian Biology Co.,Ltd

public_traded

Wuhan Keqian Biology Co.,Ltd is publicly traded on SHH under ticker 688526.SS.

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for swine, poultry, and pets, as well as diagnostic reagents. The company was founded in 2001 and is based in Wuhan, China.

View full analysis on MarketSnap